Even During Omicron, Pfizer Vaccine Slashed Hospitalizations for Kids Aged 5 to 11

Newest Coronavirus Information

News Picture: Even During Omicron, Pfizer Vaccine Slashed Hospitalizations for Kids Aged 5 to 11

THURSDAY, March 31, 2022 (HealthDay Information)

The Pfizer COVID vaccine considerably lowered U.S. youngsters’s danger of extreme sickness and hospitalization throughout the current Omicron surge, based on a brand new research.

However researchers famous that solely 27% of 5- to 11-year-olds in the US and simply 57% of 12- to 17-year-olds had acquired two vaccine doses as of March 16, and mentioned they hoped their findings would assist persuade reluctant parents to get their youngsters vaccinated.

“The rationale for a kid to get a COVID-19 vaccine is to stop extreme issues of SARS-CoV-2 an infection, together with hospitalization,” mentioned research co-leader Dr. Adrienne Randolph, of Boston Kids’s Hospital and the U.S. Facilities for Illness Management and Prevention.

The Pfizer vaccine grew to become accessible in the US in December 2020 for individuals 16 or older; for 12- to 15-year-olds in Might 2021; and for 5- to 11-year-olds in October 2021.

For the new study, Randolph’s workforce analyzed knowledge on 267 youngsters aged 5 to 11 years, and 918 youngsters aged 12 to 18 hospitalized with COVID-19 between July 2021 and Feb. 17, 2022.

Total, 88% had been unvaccinated and 25% had been critically sick and required life help measures resembling intubation.

Amongst 5- to 11-year-olds, 92% had been unvaccinated and 16% had been critically sick. Of those that had been critically sick, 90% had been unvaccinated, the researchers mentioned.

Amongst 12- to 18-year-olds, 87% had been unvaccinated and 27% had been critically sick. Of those that had been critically sick, 93% had been unvaccinated. Two sufferers on this age group died, based on the report.

Based mostly on this knowledge, the research authors calculated that two doses of the Pfizer vaccine had been 68% efficient in stopping hospitalization amongst youngsters between 5 and 11 years of age throughout the Omicron surge.

As a result of youngsters on this age group solely grew to become eligible for the vaccine in October, there weren’t ample numbers to guage its impression on the chance of essential sickness throughout the Omicron surge, or the way it affected the chance of hospitalization and demanding sickness throughout the Delta surge that preceded it, the researchers defined.

Amongst 12- to 18-year-olds, two doses of the Pfizer vaccine had been 92% efficient in opposition to hospitalization throughout the Delta surge, and 40% efficient throughout the Omicron wave.

On this age group, vaccination was 96% efficient in stopping essential sickness throughout Delta and 79% efficient throughout the Omicron surge, based on the report revealed March 30 within the New England Journal of Drugs.

“This proof reveals that vaccination reduces this danger considerably in 5- to 11-year-olds. And whereas vaccination offered adolescents with decrease safety in opposition to hospitalization with Omicron versus Delta, it prevented essential sickness from each variants,” Randolph mentioned in a hospital information launch.

Randolph mentioned she hopes dad and mom will get their youngsters and teens vaccinated. A extremely contagious Omicron subvariant referred to as BA.2 is now the dominant cause of COVID-19 in the US.

The brand new research reveals that even vaccines focused on the unique variant of SARS-CoV-2 “are extraordinarily efficient at stopping essential sickness,” mentioned Dr. Amesh Adalja, senior scholar on the Johns Hopkins Heart for Well being Safety, in Baltimore. “These findings spotlight the facility of the vaccines to shift COVID-19 to a milder spectrum of sickness.”

Extra info

For extra on COVID-19 vaccines and youngsters, go to the American Academy of Pediatrics.

SOURCES: Boston Kids’s Hospital, information launch, March 30, 2022; Amesh Adalja, MD, senior scholar, Johns Hopkins Heart for Well being Safety, Baltimore

By Robert Preidt HealthDay Reporter

Copyright © 2021 HealthDay. All rights reserved.


Leave a Reply

Your email address will not be published.